References
- Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021 [Internet]. [cited 2025 Nov 3]. Available from: https://www.who.int/publications/i/item/9789240027077
- Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet Lond Engl. 2016 Sept 10;388(10049):1081–8.
- Gheorghe L, Sporea I, Iacob S, Sirli R, Trifan A, Diculescu M, et al. Position Paper on Treatment of Hepatitis C in Romania 2017. Part Two. J Gastrointest Liver Dis JGLD. 2017 Sept;26(3):309–17.
- Tavoschi L, Mason L, Petriti U, Bunge E, Veldhuijzen I, Duffell E. Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area. J Hosp Infect. 2019 Aug;102(4):359–68.
- Westermann C, Peters C, Lisiak B, Lamberti M, Nienhaus A. The prevalence of hepatitis C among healthcare workers: a systematic review and meta-analysis. Occup Environ Med. 2015 Dec;72(12):880–8.
- Kostrzewa M, Seyyedsalehi MS, Godono A, Collatuzzo G, Fiorini G, Moscato S, et al. Cancer Prevention at Work (CPW) project: Rationale, framework and research protocol. PLOS ONE. 2025 Nov 3;20(11):e0335752.
- Linas BP, Hu H, Barter DM, Horberg M. Hepatitis C Screening Trends in a Large Integrated Health System. Am J Med. 2014 May;127(5):398–405.
- Malka E, Streinu-Cercel A, Piţigoi D, Bacruban R. Management of accidental exposure to HCV, HBV and HIV in healthcare workers in Romania. Germs. 2012 Dec 1;2(4):137–41.
- Yamashita S, Kanda N, Hashimoto H, Yoshimoto H, Goda K, Mitsutake N, et al. Trends in the healthcare burden of hepatitis C after the introduction of direct-acting antivirals in Japan, 2013-2022: A national claims database study in Japan. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2025 Nov;160:108043.
- Tatemichi M, Furuya H, Nagahama S, Takaya N, Shida Y, Fukai K, et al. A nationwide cross-sectional survey on hepatitis B and C screening among workers in Japan. Sci Rep. 2020 July 10;10(1):11435.
- Gheorghe L, Iacob S, Csiki IE, Huiban L, Cojocaru M, Cojocariu C, et al. The Prevalence of HCV Infection and Risk Factors in a Hospital-Based Population Screening, a First Step to the Micro-Elimination of HCV Infection in Medical Institutions from Romania - Results of the HepC ALERT Study. J Gastrointestin Liver Dis. 2020 Dec 12;29(4):587–93.
- King H, Soh JE, Thompson WW, Brown JR, Rapposelli K, Vellozzi C. Testing for Hepatitis C Virus Infection Among Adults Aged ≥18 in the United States, 2013-2017. Public Health Rep Wash DC 1974. 2022;137(6):1107–17.
- Taye BW. Hepatitis C virus infection and tobacco smoking - joint health effects and implications for treatment of both: A systematic review [Internet]. medRxiv; 2021 [cited 2025 Nov 3]. p. 2021.10.12.21264923. Available from: https://www.medrxiv.org/content/10.1101/2021.10.12.21264923v1
- Lin B, Ma H, Lin Y, Lin T, Han X, Lin M, et al. Ascertaining the association between smoking behaviors and viral hepatitis risk: A Mendelian randomization approach. Tob Induc Dis. 2025 July 26;23(July):1–9.
- Kim RS, Weinberger AH, Chander G, Sulkowski MS, Norton B, Shuter J. Cigarette Smoking in Persons Living with Hepatitis C: The National Health and Nutrition Examination Survey (NHANES), 1999-2014. Am J Med. 2018 June;131(6):669–75.
- Wang CS, Wang ST, Chang TT, Yao WJ, Chou P. Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression. Arch Intern Med. 2002 Apr 8;162(7):811–5.